美农生物
(301156)
| 流通市值：13.50亿 | | | 总市值：21.01亿 |
| 流通股本：1.18亿 | | | 总股本：1.84亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 327,552,727.24 | 159,023,381.03 | 561,265,718.82 | 390,128,929.24 |
| 营业总成本 | 299,318,883.41 | 138,733,565.05 | 504,072,553.74 | 348,508,534.53 |
| 其他经营收益 | | | | |
| 营业利润 | 19,555,239.75 | 14,365,945.54 | 60,582,308.83 | 45,457,413.51 |
| 利润总额 | 19,501,503.32 | 14,362,527.61 | 60,769,462.1 | 45,773,317.49 |
| 净利润 | 18,061,008.98 | 13,452,263.21 | 54,810,535.8 | 40,918,189.51 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 18,061,008.98 | 13,452,263.21 | 54,810,535.8 | 40,918,189.51 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 414,794,768.37 | 451,650,052.56 | 412,351,035.06 | 393,763,620.83 |
| 非流动资产: | | | | |
| 非流动资产合计 | 394,815,745.79 | 411,901,215.55 | 416,690,167.59 | 389,933,969.66 |
| 资产总计 | 809,610,514.16 | 863,551,268.11 | 829,041,202.65 | 783,697,590.49 |
| 流动负债: | | | | |
| 流动负债合计 | 78,767,007.57 | 112,990,922.8 | 96,375,903.95 | 54,838,009.79 |
| 非流动负债: | | | | |
| 非流动负债合计 | 2,016,965.44 | 2,524,863.95 | 2,424,545.49 | 2,583,022.88 |
| 负债合计 | 80,783,973.01 | 115,515,786.75 | 98,800,449.44 | 57,421,032.67 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 728,826,541.15 | 748,035,481.36 | 730,240,753.21 | 726,276,557.82 |
| 股东权益合计 | 728,826,541.15 | 748,035,481.36 | 730,240,753.21 | 726,276,557.82 |
| 负债和股东权益合计 | 809,610,514.16 | 863,551,268.11 | 829,041,202.65 | 783,697,590.49 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 350,776,233.91 | 163,746,728.81 | 601,453,299.48 | 444,938,766.91 |
| 经营活动现金流出小计 | 357,704,819.57 | 163,688,215.85 | 534,963,890.11 | 367,345,922.33 |
| 经营活动产生的现金流量净额 | -6,928,585.66 | 58,512.96 | 66,489,409.37 | 77,592,844.58 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 20,324,329.82 | 3,507,859.33 | 106,552,582.01 | 106,471,462.01 |
| 投资活动现金流出小计 | 21,626,644.86 | 12,326,844.85 | 186,730,845.37 | 180,218,457.17 |
| 投资活动产生的现金流量净额 | -1,302,315.04 | -8,818,985.52 | -80,178,263.36 | -73,746,995.16 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 42,298,714.26 | 14,085,495.82 | 63,165,401.39 | 63,165,401.39 |
| 筹资活动产生的现金流量净额 | -42,298,714.26 | -14,085,495.82 | -63,165,401.39 | -63,165,401.39 |
| 汇率变动对现金及现金等价物的影响 | -3,963,352.4 | -1,872,810.12 | -426,554.35 | 250,019.99 |
| 现金及现金等价物净增加额 | -54,492,967.36 | -24,718,778.5 | -77,280,809.73 | -59,069,531.98 |
| 期末现金及现金等价物余额 | 128,474,082.57 | 158,248,271.43 | 182,967,049.93 | 201,178,327.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -54,492,967.36 | - | -77,280,809.73 | - |